Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1329370rdf:typepubmed:Citationlld:pubmed
pubmed-article:1329370lifeskim:mentionsumls-concept:C0206435lld:lifeskim
pubmed-article:1329370lifeskim:mentionsumls-concept:C0025885lld:lifeskim
pubmed-article:1329370lifeskim:mentionsumls-concept:C0162326lld:lifeskim
pubmed-article:1329370lifeskim:mentionsumls-concept:C1883559lld:lifeskim
pubmed-article:1329370lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1329370lifeskim:mentionsumls-concept:C1521871lld:lifeskim
pubmed-article:1329370lifeskim:mentionsumls-concept:C0018367lld:lifeskim
pubmed-article:1329370pubmed:issue3lld:pubmed
pubmed-article:1329370pubmed:dateCreated1992-11-6lld:pubmed
pubmed-article:1329370pubmed:abstractTextThe extensive nucleotide sequence heterogeneity among independent genotypes of wild polioviruses permits the systematic design of genotype-specific molecular reagents. We have prepared two sets of polymerase chain reaction (PCR) primer pairs specific for the genotype of wild poliovirus type 3 recently endemic to Mexico and Guatemala. Nucleotide sequences of a representative wild type 3 virus isolated in Mexico in 1989 differed from the corresponding Sabin 3 (Leon 12 a1b) sequences at 167 of 900 positions within the VP1 region. From the sequence data, wild virus-specific primer pairs were designed to complement regions of high mismatch (greater than 33%) with Sabin 3 templates. Primer binding sites were spaced along the genome so that the predicted amplification products (142 bp and 163 bp) could be easily resolved electrophoretically from the products generated with our Sabin strain-specific primers (Sabin 1: 97 bp; Sabin 2: 71 bp; Sabin 3: 53 bp). RNAs of all wild type 3 poliovirus isolates from Mexico and Guatemala obtained over a 13-year period (1977-1990) served as efficient templates for amplification of the 142-bp and 163-bp products. Genomic templates derived from vaccine-related polioviruses and most heterologous wild polioviruses were inactive under equivalent reaction conditions. Amplifications generating a 114-bp product with a broadly reacting primer pair, matching highly conserved sequences in the 5'-noncoding region, provided a positive control for the presence in samples of poliovirus (or enterovirus) RNAs. Selective amplification of wild Mexico-Guatemala type 3 poliovirus sequences was obtained with either primer set in reactions containing large stoichiometric excesses (up to 10(6)-fold) of vaccine-related RNAs. We have used wild genotype-specific PCR primer sets to facilitate identification of wild polioviruses present in both clinical and environmental samples.lld:pubmed
pubmed-article:1329370pubmed:languageenglld:pubmed
pubmed-article:1329370pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1329370pubmed:citationSubsetIMlld:pubmed
pubmed-article:1329370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1329370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1329370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1329370pubmed:statusMEDLINElld:pubmed
pubmed-article:1329370pubmed:monthAuglld:pubmed
pubmed-article:1329370pubmed:issn0168-1702lld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:MeeM SMSlld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:CruzJ RJRlld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:Ruiz GómezJJlld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:PallanschM...lld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:YangS JSJlld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:YangC FCFlld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:LuxL BLBlld:pubmed
pubmed-article:1329370pubmed:authorpubmed-author:HollowayB PBPlld:pubmed
pubmed-article:1329370pubmed:issnTypePrintlld:pubmed
pubmed-article:1329370pubmed:volume24lld:pubmed
pubmed-article:1329370pubmed:ownerNLMlld:pubmed
pubmed-article:1329370pubmed:authorsCompleteYlld:pubmed
pubmed-article:1329370pubmed:pagination277-96lld:pubmed
pubmed-article:1329370pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:meshHeadingpubmed-meshheading:1329370-...lld:pubmed
pubmed-article:1329370pubmed:year1992lld:pubmed
pubmed-article:1329370pubmed:articleTitleGenotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala.lld:pubmed
pubmed-article:1329370pubmed:affiliationDivision of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, GA 30333.lld:pubmed
pubmed-article:1329370pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1329370pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1329370lld:pubmed